Research interest extends to circadian rhythm regulation, age-associated gene expression patterns, antioxidant defense pathways, and longevity-related endpoints in rodent and human aging studies
PROTECT THE PRODUCT FROM LIGHT
Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
Decades of subsequent preclinical research documented BPC-157 activity across gastrointestinal tissue, tendons, ligaments, bone, and the nervous system